65
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Effect of quantitative intraocular pressure reduction on visual field defect progression in normal tension glaucoma under medical therapy applying Markov model

, , &
Pages 1617-1624 | Published online: 30 Aug 2018

References

  • YoshikawaKSantoKHizakiHHashimotoMLong-term progression of visual field defects and related factors in medically treated normal tension glaucomaClin Ophthalmol20181224725329440866
  • HeijlABuchholzPNorrgrenGBengtssonBRates of visual field progression in clinical glaucoma careActa Ophthalmol201391540641223066646
  • MikelbergFSDranceSMThe mode of progression of visual field defects in glaucomaAm J Ophthalmol19849844434456486216
  • Casas-LleraPRebolledaGMuñoz-NegreteFJArnalich-MontielFPérez-LópezMFernández-BuenagaRVisual field index rate and event-based glaucoma progression analysis: comparison in a glaucoma populationBr J Ophthalmol200993121576157919535357
  • KayRA Markov model for analysing cancer markers and disease states in survival studiesBiometrics19864248558652434150
  • StandfieldLBComansTAScuffhamPAAn empirical comparison of Markov cohort modeling and discrete event simulation in a capacity-constrained health care settingEur J Health Econ2017181334726715578
  • ByunJHParkJAKangHRShinJYLeeEKComparison of effectiveness between delamanid and bedaquiline among patients with multidrug-resistant tuberculosis: a Markov model simulation StudyClin Drug Investig20163611957968
  • BoodhnaTCrabbDPMore frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in EnglandBMC Health Serv Res201616161127770792
  • Azuara-BlancoABanisterKBoachieCAutomated imaging technologies for the diagnosis of glaucoma: a comparative diagnostic study for the evaluation of the diagnostic accuracy, performance as triage tests and cost-effectiveness (GATE study)Health Technol Assess20162081168
  • BelghithABowdCMedeirosFABalasubramanianMWeinrebRNZangwillLMGlaucoma progression detection using nonlocal Markov random field priorJ Med Imaging201413034504
  • KymesSMLambertDLLeePPThe development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA modelOphthalmology201211971367137422537616
  • MuñozASunyerJComparison of semiparametric and parametric survival models for the analysis of bronchial responsivenessAm J Respir Crit Care Med19961546 Pt 2S234S2398970394
  • SekineMAraieMSuzukiYKosekiNStudy on risk factors for progression of visual field damage in normal-tension glaucomaNippon Ganka Gakkai Zasshi19949843693738165969
  • KymesSMKassMAAndersonDRMillerJPGordonMOfor Ocular Hypertension Treatment Study Group (OHTS)Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment StudyAm J Ophthalmol20061416997100816765666
  • KomoriSIshidaKYamamotoTResults of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-upGraefes Arch Clin Exp Ophthalmol2014252121963197025128961
  • MikelbergFSSchulzerMDranceSMLauWThe rate of progression of scotomas in glaucomaAm J Ophthalmol19861011163942160
  • LeeJKongMKimJKeeCComparison of visual field progression between relatively low and high intraocular pressure groups in normal tension glaucoma patientsJ Glaucoma201423855356023751927
  • NaitoTYoshikawaKMizoueSRelationship between consecutive deterioration of mean deviation value and progression of visual field defect in open-angle glaucomaClin Ophthalmol201592217222226648689
  • Collaborative Normal-Tension Glaucoma Study GroupComparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study GroupAm J Ophthalmol199812644874979780093
  • Japan glaucoma societyThe Japan Glaucoma Society Guidelines for Glaucoma (4th Edition)]. 2018 Jan2018 http://www.nichigan.or.jp/member/guideline/glaucoma4.pdfAccessed July 20, 2018
  • NordmannJPLafumaADeschaseauxCBerdeauxGClinical outcomes of glaucoma treatments over a patient lifetime: a Markov modelJ Glaucoma200514646346916276278
  • KimMKimDMParkKHKimTWJeoungJWKimSHIntraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up studyActa Ophthalmol2013914e270e27523406253
  • SakataRAiharaMMurataHContributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatmentJ Glaucoma201322325025423059475
  • ErdemEWilliamsAKucharSDWaisbourdMSpaethGLLong-term (>8 years) evaluation of progression in patients with low-pressure glaucomaEur J Ophthalmol201525649049525982210